Sale!

CLCN1 Gene Myotonia Congenita Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CLCN1 Gene Myotonia Congenita Genetic Test is a specialized diagnostic tool designed to identify mutations in the CLCN1 gene, which are responsible for causing Myotonia Congenita. This condition is a genetic disorder characterized by muscle stiffness and delayed relaxation of muscles after contraction. The test involves analyzing the patient’s DNA to detect any genetic anomalies in the CLCN1 gene that might lead to the development of Myotonia Congenita.

Conducted at DNA Labs UAE, a leading facility in genetic testing, the test offers a comprehensive evaluation to help in the diagnosis and management of this condition. The cost of the test is 4400 AED, reflecting the intricate technology and expertise required to accurately identify mutations in the CLCN1 gene. This test is crucial for individuals experiencing symptoms of Myotonia Congenita or those with a family history of the condition, as it can provide valuable insights into treatment options and genetic counseling.

Description

CLCN1 Gene Myotonia Congenita Genetic Test

Test Name: CLCN1 Gene Myotonia Congenita Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for CLCN1 Gene Myotonia Congenita NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CLCN1 Gene Myotonia Congenita.

Test Details:

The CLCN1 gene is responsible for encoding a protein called chloride channel 1, which plays a crucial role in muscle contraction and relaxation. Mutations in the CLCN1 gene can lead to a condition called myotonia congenita, which is characterized by muscle stiffness and difficulty relaxing after contraction.

NGS (Next-Generation Sequencing) is a genetic testing method that allows for the simultaneous analysis of multiple genes, including the CLCN1 gene, to identify any genetic variations or mutations that may be present. This type of testing can provide a comprehensive assessment of the CLCN1 gene and help diagnose myotonia congenita.

By identifying specific mutations in the CLCN1 gene through NGS testing, healthcare professionals can confirm a diagnosis of myotonia congenita and provide appropriate treatment and management strategies for affected individuals.

Additionally, NGS testing can also help identify carriers of the CLCN1 gene mutations, which can be useful for family planning and genetic counseling purposes.

Test Name	CLCN1 Gene Myotonia congenita Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Neurological Disorders
Doctor	Neurologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for CLCN1 Gene Myotonia congenita NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CLCN1 Gene Myotonia congenita
Test Details	The CLCN1 gene is responsible for encoding a protein called chloride channel 1, which plays a crucial role in muscle contraction and relaxation. Mutations in the CLCN1 gene can lead to a condition called myotonia congenita, which is characterized by muscle stiffness and difficulty relaxing after contraction. NGS (Next-Generation Sequencing) is a genetic testing method that allows for the simultaneous analysis of multiple genes, including the CLCN1 gene, to identify any genetic variations or mutations that may be present. This type of testing can provide a comprehensive assessment of the CLCN1 gene and help diagnose myotonia congenita. By identifying specific mutations in the CLCN1 gene through NGS testing, healthcare professionals can confirm a diagnosis of myotonia congenita and provide appropriate treatment and management strategies for affected individuals. Additionally, NGS testing can also help identify carriers of the CLCN1 gene mutations, which can be useful for family planning and genetic counseling purposes.